Biotechnology, Pharmaceuticals, Health Care/Life Sciences, Biopharmaceuticals, Regulation/Government Policy, Regulatory Bodies, Corporate/Industrial News, Political/General News, Respiratory Tract Diseases

Biotechnology, Pharmaceuticals

U.K. Limits AstraZeneca Covid-19 Vaccine to Over-30s Amid Blood-Clot Concerns

The U.K.’s vaccines advisory body said AstraZeneca’s Covid-19 vaccine should preferably not be given to patients under 30 following concerns that it might cause potentially deadly blood clots in very rare instances.

4/7/2021 6:02:00 PM

People under 30 in Britain should be offered an alternative to AstraZeneca's Covid-19 vaccine due to very rare cases of blood clotting, the U.K.'s medical regulator said. The EU's health agency said the vaccine’s benefits still outweigh its risks.

The U.K.’s vaccines advisory body said AstraZeneca’s Covid-19 vaccine should preferably not be given to patients under 30 following concerns that it might cause potentially deadly blood clots in very rare instances.

following reports that people who had received it developed rare blood clots and that some had died, further slowing Europe’s already slow vaccination rollout.On Wednesday, EMA officials said that most clots that have been identified were in people under age 60 and women, but cautioned that the data didn’t pinpoint a clear link because it remained unclear how representative recipients of the AstraZeneca vaccine are within the overall population.

Jennifer Lopez and Alex Rodriguez Officially Break Up - E! Online Outfit Just Screams Police Officer CNCO Has No Limits

“Some of that could be explained by how the vaccine is being used,” said Sabine Straus, chair of the EMA’s safety committee, of possible higher-risk groups.EMA Executive Director Emer Cooke said that because the clots are so rare, the risk of death from Covid-19 is much greater than the risk of dying from the possible side effects.

Related Video​Europe's top drug regulator endorsed AstraZeneca's vaccine after it was suspended in several countries over blood-clot concerns. WSJ explains what's at stake for a shot that's been widely used around the world and may soon be considered for emergency use in the U.S. Photo: Mykola Tys/SOPA Images headtopics.com

Read more: The Wall Street Journal »

What's Up: April 2021 Skywatching Tips from NASA

What are some skywatching highlights in April 2021? Look for the rosy arch known as the Belt of Venus at sunset, then find the constellation Leo overhead on ...

Benefits outweigh risks 😂🤣.. it’s sorta rare, so don’t even worry about it. Probably won’t happen. You’ll definitely be protected from the virus and we’ll follow up on those new blood clots 🤷🏻‍♂️ Officially admitted - British Astra Zeneca side effects is death That's a strange thing for the EU's health agency to say considering that no vaccine has a better survivable rate against COVID than the 99% natural immunity people have against it.